2025 HCPCS code J1245
Injection, dipyridamole, per 10 mg
Modifiers may be applicable to clarify specific circumstances of the drug's use, wastage, or payer policies. Examples include JW modifier (drug amount discarded) and JZ modifier (zero drug wastage).
Medical necessity must be supported by documentation of a diagnosis for which dipyridamole is an indicated treatment, such as prevention of thromboembolic events in at-risk patients or use in diagnostic imaging procedures.
This code represents the supply of the drug only, not the administration. Healthcare professionals are responsible for ensuring correct dosage, appropriate intravenous administration, and monitoring the patient for adverse reactions. The drug's use is primarily for preventing blood clots, often post-heart valve replacement surgery.
In simple words: This code covers the dipyridamole injection, a medication used to prevent blood clots, given through a vein. Each unit of this code is for 10 milligrams of the medicine.
Dipyridamole is an antithrombotic agent that prevents blood clots. This code represents 10 mg of dipyridamole administered intravenously.
Example 1: A patient has recently undergone heart valve replacement surgery and requires dipyridamole to prevent post-surgical blood clot formation. The J1245 code is used to bill for each 10 mg of dipyridamole injected., A patient with a history of thromboembolic events is prescribed dipyridamole as part of their ongoing treatment. J1245 is used to report each 10mg dose administered intravenously., In a diagnostic setting, dipyridamole is used as a vasodilator during a myocardial perfusion imaging test. The J1245 code captures the amount of dipyridamole administered.
Documentation should include the diagnosis necessitating dipyridamole, the dosage administered, the route of administration (intravenous), and any relevant patient history or reactions.
** Dipyridamole is a generic drug. Brand names include Persantine and Persantine IV. Always check specific payer guidelines for coverage and documentation requirements.
- Payment Status: Active
- Specialties:Cardiology, Cardiovascular Surgery, Interventional Radiology, potentially other specialties depending upon the specific clinical use case
- Place of Service:Inpatient Hospital, Outpatient Hospital, Ambulatory Surgical Center, Physician's Office, and other settings where intravenous injections are performed.